Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Revenue (2021 - 2025)

HeartSciences (HSCS) has disclosed Revenue for 5 consecutive years, with $2419.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 102.06% year-over-year to $2419.0, compared with a TTM value of -$356010.0 through Oct 2025, down 183.85%, and an annual FY2025 reading of $4350.0, down 76.61% over the prior year.
  • Revenue was $2419.0 for Q4 2025 at HeartSciences, up from $1900.0 in the prior quarter.
  • Across five years, Revenue topped out at $14700.0 in Q1 2024 and bottomed at -$180852.0 in Q2 2025.
  • Average Revenue over 5 years is -$35305.1, with a median of $2184.5 recorded in 2023.
  • Peak annual rise in Revenue hit 653.85% in 2024, while the deepest fall reached 3115.33% in 2024.
  • Year by year, Revenue stood at $7484.0 in 2021, then plummeted by 57.24% to $3200.0 in 2022, then increased by 21.88% to $3900.0 in 2023, then tumbled by 3115.33% to -$117598.0 in 2024, then soared by 102.06% to $2419.0 in 2025.
  • Business Quant data shows Revenue for HSCS at $2419.0 in Q4 2025, $1900.0 in Q3 2025, and -$180852.0 in Q2 2025.